B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MAOA

MOLECULAR TARGET

monoamine oxidase A

UniProt: P21397NCBI Gene: 412833 compounds

MAOA (monoamine oxidase A) is targeted by 33 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MAOA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Iproniazid4.4282
2Moclobemide3.0921
3Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is2.309
4Apigenin 5,7,4'-trihydroxy-flavone,1.956
5Quercetin1.795
6Phenelzine1.795
7Genistein1.393
8Idazoxan1.393
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
10Harmaline1.102
11hispidol1.102
12Linezolid1.102
13Vitamin K 31.102
141-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine1.102
15chrysin0.691
16Methylene Blue0.691
17myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
18plumbagin [Supplementary Concept]0.691
19Sirolimus0.691
20Rutin0.691
21Aripiprazole0.691
22auraptene0.691
23Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
24Famotidine0.691
25Fentanyl0.691
26Guanabenz0.691
27Guanfacine0.691
28juglone hydroxylase [Supplementary Concept] catalyzes0.691
29Lynestrenol0.691
301-(5,8-dihydro-1,4-dihydroxy-5,8-dioxo-2-naphthyl)-4-methylpent-3-en-1-yl cinnamate [Supplementary Concept]0.691
31pentamidine0.691
32Rilmenidine Oxazole derivative that acts as0.691
33Sorafenib0.691

About MAOA as a Drug Target

MAOA (monoamine oxidase A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 33 compounds with documented MAOA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MAOA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.